Non-traditional gene fusions in luminal breast cancer: A new target for therapy

FHS
August 22, 2023
12:11 am

A new editorial paper was published in Oncotarget’s Volume 14 on June 12, 2023, entitled, “Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?”

Kentucky First State to Decriminalize Medical Errors

Kentucky has become the first state to decriminalize medical errors — a move many medical associations support. HB 159 was signed by Kentucky’s Democratic Gov.

May 2, 2024

CDC Advisors Endorse Maternal RSV Vax to Protect Newborns

The CDC’s advisors on Friday recommended a maternal respiratory syncytial virus (RSV) vaccine to protect infants from serious infections. By an 11-1 vote, the Advisory

September 23, 2023

Viking to push obesity drug to Phase 3 in bid to reach market faster

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.